Organization | Sanliurfa Mehmet Akif Inan Education and Research Hospital

Sanliurfa Mehmet Akif Inan Education and Research Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2014

NCT03903952

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Nefise Nazlı YENIGUL | Sanliurfa Mehmet Akif Inan Education and Research Hospital

Active Ingredients

Drugs in Other Trials (6)

betamethasone (celestone) (1 trial)

bisphenol a (1 trial)

cobalamin (1 trial)

dextrose (1 trial)

folic acid (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 4
# of Trial APIs: 6